RS62718B1 - Nova jedinjenja - Google Patents

Nova jedinjenja

Info

Publication number
RS62718B1
RS62718B1 RS20211557A RSP20211557A RS62718B1 RS 62718 B1 RS62718 B1 RS 62718B1 RS 20211557 A RS20211557 A RS 20211557A RS P20211557 A RSP20211557 A RS P20211557A RS 62718 B1 RS62718 B1 RS 62718B1
Authority
RS
Serbia
Prior art keywords
novel compounds
novel
compounds
Prior art date
Application number
RS20211557A
Other languages
English (en)
Inventor
De Francisco Esther Porras
Modesto Jesús Remuiñan-Blanco
Marilyne Bourotte
Benoit Deprez
Nicolas Willand
Original Assignee
Glaxosmithkline Ip Dev Ltd
BioVersys AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Glaxosmithkline Ip Dev Ltd, BioVersys AG filed Critical Glaxosmithkline Ip Dev Ltd
Publication of RS62718B1 publication Critical patent/RS62718B1/sr

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445Non condensed piperidines, e.g. piperocaine
    • A61K31/4523Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/4965Non-condensed pyrazines
    • A61K31/497Non-condensed pyrazines containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/50Pyridazines; Hydrogenated pyridazines
    • A61K31/501Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/506Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim not condensed and containing further heterocyclic rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04Antibacterial agents
    • A61P31/06Antibacterial agents for tuberculosis
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D401/00Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/04Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2300/00Mixtures or combinations of active ingredients, wherein at least one active ingredient is fully defined in groups A61K31/00 - A61K41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Epidemiology (AREA)
  • Communicable Diseases (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pulmonology (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
RS20211557A 2017-08-16 2018-08-15 Nova jedinjenja RS62718B1 (sr)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP17382570 2017-08-16
EP18752172.9A EP3668853B1 (en) 2017-08-16 2018-08-15 Novel compounds
PCT/EP2018/072144 WO2019034701A1 (en) 2017-08-16 2018-08-15 NEW COMPOUNDS

Publications (1)

Publication Number Publication Date
RS62718B1 true RS62718B1 (sr) 2022-01-31

Family

ID=59713958

Family Applications (1)

Application Number Title Priority Date Filing Date
RS20211557A RS62718B1 (sr) 2017-08-16 2018-08-15 Nova jedinjenja

Country Status (21)

Country Link
US (1) US11969423B2 (sr)
EP (1) EP3668853B1 (sr)
JP (1) JP7183270B2 (sr)
KR (1) KR102657861B1 (sr)
CN (1) CN111225910B (sr)
AU (1) AU2018317805B2 (sr)
BR (1) BR112020003221A2 (sr)
CA (1) CA3072839A1 (sr)
CY (1) CY1124865T1 (sr)
DK (1) DK3668853T3 (sr)
ES (1) ES2902600T3 (sr)
HR (1) HRP20211894T1 (sr)
HU (1) HUE057050T2 (sr)
LT (1) LT3668853T (sr)
PL (1) PL3668853T3 (sr)
PT (1) PT3668853T (sr)
RS (1) RS62718B1 (sr)
RU (1) RU2767652C2 (sr)
SI (1) SI3668853T1 (sr)
WO (1) WO2019034701A1 (sr)
ZA (1) ZA202000586B (sr)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE10250080A1 (de) 2002-10-25 2004-05-13 Boehringer Ingelheim Pharma Gmbh & Co. Kg Ausgewählte CGRP-Antagonisten, Verfahren zu deren Herstellung sowie deren Verwendung als Arzneimittel
FR2903405B1 (fr) 2006-07-04 2011-09-09 Pasteur Institut Composes a effet potentialisateur de l'activite de l'ethionamide et leurs applications
EP2439205B1 (en) 2006-12-29 2015-03-11 AbbVie Deutschland GmbH & Co KG Carboxamide compounds and their use as calpain inhibitors
FR2939135B1 (fr) * 2008-12-02 2010-12-03 Galderma Res & Dev Nouveaux composes 4-(azacycloalkyl)-benzene-1,3-diol comme inhibiteurs de la tyrosinase, leur procede de preparation et leur utilisation en medecine humaine ainsi qu'en cosmetique
EP2771338A2 (en) * 2011-10-25 2014-09-03 Université de Droit et de la Santé de Lille 2 1, 2, 4 - oxadiazole derivatives as ethr inhibitors for use in the treatment tuberculosis
FR3000065A1 (fr) * 2012-12-21 2014-06-27 Univ Lille Ii Droit & Sante Composes bicycliques ayant une activite potentialisatrice de l'activite d'un antibiotique actif contre les mycobacteries-composition et produit pharmaceutiques comprenant de tels composes

Also Published As

Publication number Publication date
DK3668853T3 (da) 2021-12-06
CA3072839A1 (en) 2019-02-21
SI3668853T1 (sl) 2022-02-28
HUE057050T2 (hu) 2022-04-28
ZA202000586B (en) 2021-08-25
PT3668853T (pt) 2021-12-02
EP3668853A1 (en) 2020-06-24
US11969423B2 (en) 2024-04-30
CN111225910B (zh) 2023-03-24
JP7183270B2 (ja) 2022-12-05
WO2019034701A1 (en) 2019-02-21
KR102657861B1 (ko) 2024-04-17
RU2767652C2 (ru) 2022-03-18
KR20200041345A (ko) 2020-04-21
PL3668853T3 (pl) 2022-01-31
AU2018317805B2 (en) 2021-04-15
EP3668853B1 (en) 2021-09-29
BR112020003221A2 (pt) 2020-10-06
CN111225910A (zh) 2020-06-02
HRP20211894T1 (hr) 2022-08-19
JP2020531576A (ja) 2020-11-05
AU2018317805A1 (en) 2020-02-20
CY1124865T1 (el) 2022-11-25
US20200253967A1 (en) 2020-08-13
ES2902600T3 (es) 2022-03-29
RU2020109672A3 (sr) 2021-10-18
LT3668853T (lt) 2022-03-10
RU2020109672A (ru) 2021-09-16

Similar Documents

Publication Publication Date Title
IL272562A (en) new compounds
GB201720187D0 (en) Novel Compounds
GB201702947D0 (en) Novel compounds
ZA202000586B (en) Novel compounds
GB201721731D0 (en) Novel compounds
GB201721732D0 (en) Novel Compounds
GB201721736D0 (en) Novel Compounds
GB201721727D0 (en) Novel compounds
GB201721726D0 (en) Novel compounds
GB201721735D0 (en) Novel Compounds
GB201719720D0 (en) Novel compounds
GB201718561D0 (en) Novel compounds
GB201718563D0 (en) Novel compounds
GB201718564D0 (en) Novel compounds
GB201718565D0 (en) Novel compounds
GB201716131D0 (en) Novel compounds
GB201714699D0 (en) Novel compounds
GB201713079D0 (en) Novel Compounds
GB201713076D0 (en) Novel compounds
GB201713083D0 (en) Novel compounds
GB201713082D0 (en) Novel compounds
GB201713085D0 (en) Novel compounds
GB201711682D0 (en) Novel compounds
GB201711549D0 (en) Novel compounds
GB201710942D0 (en) Novel compounds